ico

PIC32MX1XX/2XX Family Silicon Errata and Data Sheet Clarification

PIC32MX1XX/2XX Family Silicon Errata and Data Sheet Clarification




ico

PIC32MX1XX/2XX/5XX 64/100-pin Family Silicon Errata and Data Sheet Clarification

PIC32MX1XX/2XX/5XX 64/100-pin Family Silicon Errata and Data Sheet Clarification




ico

PIC32MX534/564/664/764 Family Silicon Errata and Data Sheet Clarification

PIC32MX534/564/664/764 Family Silicon Errata and Data Sheet Clarification




ico

PIC32MX320/340/360/440/460 Family Silicon Errata and Data Sheet Clarification

PIC32MX320/340/360/440/460 Family Silicon Errata and Data Sheet Clarification




ico

PIC18F26/46/56Q43 Silicon Errata and Data Sheet Clarifications

PIC18F26/46/56Q43 Silicon Errata and Data Sheet Clarifications




ico

PIC18F25/45/55Q43 Silicon Errata and Data Sheet Clarifications

PIC18F25/45/55Q43 Silicon Errata and Data Sheet Clarifications




ico

PIC18F27/47/57Q43 Family Silicon Errata and Data Sheet Clarifications

PIC18F27/47/57Q43 Family Silicon Errata and Data Sheet Clarifications




ico

AVR128DA28/32/48/64 Silicon Errata and Data Sheet Clarification

AVR128DA28/32/48/64 Silicon Errata and Data Sheet Clarification




ico

PIC32MM0256GPM064 Family Silicon Errata and Data Sheet Clarification

PIC32MM0256GPM064 Family Silicon Errata and Data Sheet Clarification




ico

ATxmega128/64/32/16A4U Silicon Errata and Data Sheet Clarification

ATxmega128/64/32/16A4U Silicon Errata and Data Sheet Clarification




ico

U.S. approves helicopters to Egypt but says rights concerns remain

The United States has approved a $2.3 billion deal on attack helicopters for Egypt, but an official insisted Friday that Washington was still pressing on human rights concerns.




ico

SST Announces Qualification of Smartbit™ OTP NVM Technology for ON Semiconductor’s 110 nm CMOS Process

SST Announces Qualification of Smartbit™ OTP NVM Technology for ON Semiconductor’s 110 nm CMOS Process




ico

Rep. McSally Visits Microchip Executives to Discuss Semiconductor Supply Chain Resilience in the U.S. Amid Defense Industrial Base Report Findings

Rep. McSally Visits Microchip Executives to Discuss Semiconductor Supply Chain Resilience in the U.S. Amid Defense Industrial Base Report Findings




ico

Preserving the Art of Sound: HARMAN Helps Revive Mumbai’s Iconic Royal Opera House

During the early 1900s, the city of Mumbai witnessed an unprecedented peak in social, artistic, and cultural activity. At the center of this movement was the Royal Opera House, Mumbai, India’s ‘cultural crown jewel’ and only surviving opera house. Built...




ico

No clowning around with masks on Mexico City metro

A campaign in Mexico City to get residents to wear face masks is now reinforced with a new secret weapon: clowns. They're telling metro riders, 'Wear a face mask -- don't be a clown!' as they spray riders' hands with disinfectant. Gavino Garay has more.




ico

Seed funding slows in Silicon Valley

The bloom is off seed funding, the business of providing money to brand-new startups, as investors take a more measured approach to financing emerging U.S. technology companies.




ico

Dingoes are both pest and icon. Now there's a new reason to love them

Dingoes have been persecuted in Australia for centuries for killing livestock, but protecting them could benefit the environment and aid recovery from the devastating fires




ico

Harman Kardon Celebrates 20 Years of Iconic Speaker Design with the SoundSticks 4

CES 2020 – LAS VEGAS, NV – JANUARY 6, 2020 – Harman Kardon adds to its most iconic speaker series with the SoundSticks 4. In 2000, when the original SoundSticks was introduced, it quickly became one of the most sought-after desktop sound systems. The...




ico

Color Out of Space: Another Nicolas Cage film that's so bad it's good

Nicolas Cage grapples with a weird luminous alien presence in the movie Color Out of Space. It's a story that has roots in a late-19th-century obsession with new forms of radiation, says Simon Ings




ico

Reuters Newsmaker: Washington Comes to Silicon Valley

Reuters Breakingviews examines how Washington’s new paradigm on China is affecting Silicon Valley, from overseas investments to intellectual property protection to trade.




ico

Dingoes are both pest and icon. Now there's a new reason to love them

Dingoes have been persecuted in Australia for centuries for killing livestock, but protecting them could benefit the environment and aid recovery from the devastating fires




ico

UPDATE 2-Auto production collapses by 99% in Mexico and Brazil due to coronavirus

Auto production in Mexico and Brazil, Latin America's top producers, plunged by an unprecedented 99% in April as a result of the coronavirus crisis, with the two countries building a total of just 5,569 vehicles.




ico

UPDATE 3-Mexico to unveil economic restart next week after coronavirus lockdown

Mexican President Andres Manuel Lopez Obrador said on Friday he aims to present plans next week to reopen the economy, as key sectors like carmaking look to begin business again after over a month of quarantine measures to curb the coronavirus outbreak.




ico

No clowning around with masks on Mexico City metro

A campaign in Mexico City to get residents to wear face masks is now reinforced with a new secret weapon: clowns. They're telling metro riders, 'Wear a face mask -- don't be a clown!' as they spray riders' hands with disinfectant. Gavino Garay has more.




ico

Private bridge links U.S.-Mexico

A terminal in the U.S. is now linked to the Tijuana International Airport via a cross-border bridge. Julie Noce reports.




ico

No clowning around with masks on Mexico City metro

A campaign in Mexico City to get residents to wear face masks is now reinforced with a new secret weapon: clowns. They're telling metro riders, 'Wear a face mask -- don't be a clown!' as they spray riders' hands with disinfectant. Gavino Garay has more.




ico

Dingoes are both pest and icon. Now there's a new reason to love them

Dingoes have been persecuted in Australia for centuries for killing livestock, but protecting them could benefit the environment and aid recovery from the devastating fires




ico

Dengue Fever a Major Cost Burden in Puerto Rico

Title: Dengue Fever a Major Cost Burden in Puerto Rico
Category: Health News
Created: 5/2/2012 6:05:00 PM
Last Editorial Review: 5/3/2012 12:00:00 AM




ico

Magnetic Brain Stimulation May Temporarily Dull Nicotine Craving

Title: Magnetic Brain Stimulation May Temporarily Dull Nicotine Craving
Category: Health News
Created: 4/26/2013 12:36:00 PM
Last Editorial Review: 4/29/2013 12:00:00 AM




ico

Health Tip: Managing Varicose Veins

Title: Health Tip: Managing Varicose Veins
Category: Health News
Created: 4/26/2016 12:00:00 AM
Last Editorial Review: 4/26/2016 12:00:00 AM




ico

Vampire Facials at New Mexico Spa Linked to HIV Infections

Title: Vampire Facials at New Mexico Spa Linked to HIV Infections
Category: Health News
Created: 5/1/2019 12:00:00 AM
Last Editorial Review: 5/1/2019 12:00:00 AM




ico

Evidence Builds Linking Anticoagulation to COVID-19 Survival

Data from a large US cohort suggest systemic anticoagulation may confer a survival benefit in hospitalized patients without a spike in bleeding events.




ico

What Is a Hepaticojejunostomy?

Title: What Is a Hepaticojejunostomy?
Category: Procedures and Tests
Created: 4/22/2020 12:00:00 AM
Last Editorial Review: 4/22/2020 12:00:00 AM




ico

Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective

The current coronavirus 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) infection, raises important questions as to whether pre-morbid use or continued administration of inhaled corticosteroids (ICS) affects the outcomes of acute respiratory infections due to coronavirus. Many physicians are concerned about whether individuals positive for SARS-CoV-2 and taking ICS should continue them or stop them, given that ICS are often regarded as immunosuppressive. A number of key questions arise. Are people with asthma or COPD at increased risk of developing COVID-19? Do ICS modify this risk, either increasing or decreasing it? Do ICS influence the clinical course of COVID-19? (figure 1). Whether ICS modify the risk of developing COVID-19 or the clinical course of COVID-19 in people who do not have lung disease should also be considered (figure 1).




ico

Adherence to corticosteroids and clinical outcomes in mepolizumab therapy for severe asthma

Introduction

Inhaled corticosteroids (ICS) achieve disease control in the majority of asthmatic patients, although adherence to prescribed ICS is often poor. Patients with severe eosinophilic asthma may require treatment with oral corticosteroids (OCS) and/or biologic agents such as mepolizumab. It is unknown if ICS adherence changes on, or alters clinical response to, biologic therapy.

Methods

We examined ICS adherence and clinical outcomes in OCS-dependent severe eosinophilic asthma patients who completed 1 year of mepolizumab therapy. The ICS medicines possession ratio (MPR) was calculated (the number of doses of ICS issued on prescription/expected number) for the year before and the year after biologic initiation. Good adherence was defined as MPR >0.75, intermediate 0.74–0.51 and poor <0.5. We examined outcomes after 12 months of biologic therapy, including OCS reduction and annualised exacerbation rate (AER), stratified by adherence to ICS on mepolizumab.

Results

Out of 109 patients commencing mepolizumab, 91 who had completed 12 months of treatment were included in the final analysis. While receiving mepolizumab, 68% had good ICS adherence, with 16 (18%) having poor ICS adherence. ICS use within the cohort remained similar before (MPR 0.81±0.32) and during mepolizumab treatment (0.82±0.32; p=0.78). Patients with good adherence had greater reductions in OCS dose (median (interquartile range) OCS reduction 100 (74–100)% versus 60 (27–100)%; p=0.031) and exacerbations (AER change –2.1±3.1 versus 0.3±2.5; p=0.011) than those with poor adherence. Good ICS adherence predicted the likelihood of stopping maintenance OCS (adjusted OR 3.19, 95% CI 1.02–9.94; p=0.045).

Conclusion

ICS nonadherence is common in severe eosinophilic asthma patients receiving mepolizumab, and is associated with a lesser reduction in OCS requirements and AER.




ico

Inhaled Corticosteroid Treatment in Chronic Obstructive Pulmonary Disease (COPD): Boon or Bane?

Inhaled corticosteroid (ICS)–based therapy is often used for patients with chronic obstructive pulmonary disease (COPD). However, this approach is under scrutiny because of ICS overuse in patients for whom it is not recommended and because of concerns about adverse events, particularly pneumonia, with long-term ICS use. Evidence suggests ICS may be beneficial in specific patients, namely, those with high blood eosinophil counts (eg, ≥300 cells/µL) or who are at a high risk of exacerbations. According to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2020 ABCD assessment tool, these patients belong in group D. For these patients, recommended initial treatment includes ICS in combination with long-acting β2-agonists (LABAs) when blood eosinophil counts are ≥300 cells/µL or LABA + long-acting muscarinic antagonist (LAMA) when patients are highly symptomatic, that is, with greater dyspnea and/or exercise limitation. Follow-up treatments for patients with persistent dyspnea and/or exacerbations may include LABA + ICS, LABA + LAMA, or LABA + LAMA + ICS, with use of ICS being guided by blood eosinophil counts. In this review, differences in the inflammatory mechanism underlying COPD and asthma and the role of ICS treatment in COPD are summarized. Furthermore, findings from recent clinical trials where use of ICS-based dual or triple therapy in COPD was compared with LABA + LAMA therapy and trials in which ICS withdrawal was evaluated in patients with COPD are reviewed. Finally, a step-by-step guide for ICS withdrawal in patients who are unlikely to benefit from this treatment is proposed. A video of the author discussing the overall takeaway of the review article could be downloaded from the link provided: https://www.youtube.com/watch?v=Uq7Sr5jqPDI.




ico

Forest protects Heliconius butterflies from climate extremes [INSIDE JEB]

Kathryn Knight




ico

An {alpha}7-related nicotinic acetylcholine receptor mediates the ciliary arrest response in pharyngeal gill slits of Ciona [RESEARCH ARTICLE]

Kei Jokura, Junko M. Nishino, Michio Ogasawara, and Atsuo Nishino

Ciliary movement is a fundamental process to support animal life, and the movement pattern may be altered in response to external stimuli under the control of nervous systems. Juvenile and adult ascidians have ciliary arrays around their pharyngeal gill slits (stigmata), and continuous beating is interrupted for seconds by mechanical stimuli on other parts of the body. Although it has been suggested that neural transmission to evoke ciliary arrest is cholinergic, its molecular basis has not yet been elucidated in detail. We herein attempted to clarify the molecular mechanisms underlying this neurociliary transmission in the model ascidian Ciona. Acetylcholinesterase histochemical staining showed strong signals on the laterodistal ciliated cells of stigmata, hereafter referred to as trapezial cells. The direct administration of acetylcholine (ACh) and other agonists of nicotinic ACh receptors (nAChRs) onto ciliated cells reliably evoked ciliary arrest that persisted for seconds in a dose-dependent manner. Only one isoform among all nAChR subunits encoded in the Ciona genome, called nAChR-A7/8-1, a relative of vertebrate α7 nAChRs, was expressed by trapezial cells. Exogenously expressed nAChR-A7/8-1 on Xenopus oocytes responded to ACh and other agonists with consistent pharmacological traits to those observed in vivo. Further efforts to examine signaling downstream of this receptor revealed that an inhibitor of phospholipase C (PLC) hampered ACh-induced ciliary arrest. We herein propose that homomeric α7-related nAChR-A7/8-1 mediates neurociliary transmission in Ciona stigmata to elicit persistent ciliary arrest by recruiting intracellular Ca2+ signaling.




ico

Pharmacological Characterization of the Novel and Selective {alpha}7 Nicotinic Acetylcholine Receptor-Positive Allosteric Modulator BNC375 [Neuropharmacology]

Treatments for cognitive deficits associated with central nervous system (CNS) disorders such as Alzheimer disease and schizophrenia remain significant unmet medical needs that incur substantial pressure on the health care system. The α7 nicotinic acetylcholine receptor (nAChR) has garnered substantial attention as a target for cognitive deficits based on receptor localization, robust preclinical effects, genetics implicating its involvement in cognitive disorders, and encouraging, albeit mixed, clinical data with α7 nAChR orthosteric agonists. Importantly, previous orthosteric agonists at this receptor suffered from off-target activity, receptor desensitization, and an inverted U-shaped dose-effect curve in preclinical assays that limit their clinical utility. To overcome the challenges with orthosteric agonists, we have identified a novel selective α7 positive allosteric modulator (PAM), BNC375. This compound is selective over related receptors and potentiates acetylcholine-evoked α7 currents with only marginal effect on the receptor desensitization kinetics. In addition, BNC375 enhances long-term potentiation of electrically evoked synaptic responses in rat hippocampal slices and in vivo. Systemic administration of BNC375 reverses scopolamine-induced cognitive deficits in rat novel object recognition and rhesus monkey object retrieval detour (ORD) task over a wide range of exposures, showing no evidence of an inverted U-shaped dose-effect curve. The compound also improves performance in the ORD task in aged African green monkeys. Moreover, ex vivo 13C-NMR analysis indicates that BNC375 treatment can enhance neurotransmitter release in rat medial prefrontal cortex. These findings suggest that α7 nAChR PAMs have multiple advantages over orthosteric α7 nAChR agonists for the treatment of cognitive dysfunction associated with CNS diseases.

SIGNIFICANCE STATEMENT

BNC375 is a novel and selective α7 nicotinic acetylcholine receptor (nAChR) positive allosteric modulator (PAM) that potentiates acetylcholine-evoked α7 currents in in vitro assays with little to no effect on the desensitization kinetics. In vivo, BNC375 demonstrated robust procognitive effects in multiple preclinical models across a wide exposure range. These results suggest that α7 nAChR PAMs have therapeutic potential in central nervous system diseases with cognitive impairments.




ico

Transitioning from Basic toward Systems Pharmacodynamic Models: Lessons from Corticosteroids [Review Articles]

Technology in bioanalysis, -omics, and computation have evolved over the past half century to allow for comprehensive assessments of the molecular to whole body pharmacology of diverse corticosteroids. Such studies have advanced pharmacokinetic and pharmacodynamic (PK/PD) concepts and models that often generalize across various classes of drugs. These models encompass the "pillars" of pharmacology, namely PK and target drug exposure, the mass-law interactions of drugs with receptors/targets, and the consequent turnover and homeostatic control of genes, biomarkers, physiologic responses, and disease symptoms. Pharmacokinetic methodology utilizes noncompartmental, compartmental, reversible, physiologic [full physiologically based pharmacokinetic (PBPK) and minimal PBPK], and target-mediated drug disposition models using a growing array of pharmacometric considerations and software. Basic PK/PD models have emerged (simple direct, biophase, slow receptor binding, indirect response, irreversible, turnover with inactivation, and transduction models) that place emphasis on parsimony, are mechanistic in nature, and serve as highly useful "top-down" methods of quantitating the actions of diverse drugs. These are often components of more complex quantitative systems pharmacology (QSP) models that explain the array of responses to various drugs, including corticosteroids. Progressively deeper mechanistic appreciation of PBPK, drug-target interactions, and systems physiology from the molecular (genomic, proteomic, metabolomic) to cellular to whole body levels provides the foundation for enhanced PK/PD to comprehensive QSP models. Our research based on cell, animal, clinical, and theoretical studies with corticosteroids have provided ideas and quantitative methods that have broadly advanced the fields of PK/PD and QSP modeling and illustrates the transition toward a global, systems understanding of actions of diverse drugs.

Significance Statement

Over the past half century, pharmacokinetics (PK) and pharmacokinetics/pharmacodynamics (PK/PD) have evolved to provide an array of mechanism-based models that help quantitate the disposition and actions of most drugs. We describe how many basic PK and PK/PD model components were identified and often applied to the diverse properties of corticosteroids (CS). The CS have complications in disposition and a wide array of simple receptor-to complex gene-mediated actions in multiple organs. Continued assessments of such complexities have offered opportunities to develop models ranging from simple PK to enhanced PK/PD to quantitative systems pharmacology (QSP) that help explain therapeutic and adverse CS effects. Concurrent development of state-of-the-art PK, PK/PD, and QSP models are described alongside experimental studies that revealed diverse CS actions.




ico

Low adherence to inhaled corticosteroids/long-acting {beta}2-agonists and biologic treatment in severe asthmatics

Eligibility criteria for a biologic treatment for severe asthma include poor disease control despite a full medication plan according to Global Initiative for Asthma steps 4–5 [1]. Adherence to inhaled therapy should be verified as part of that prescription requirement [2]. In fact, it has been demonstrated that poor adherence is a major cause of uncontrolled asthma, regardless of its severity [3]. Furthermore, biologics do not exert a disease-modifying effect [4]; in contrast to allergen immunotherapy, which is able to permanently modulate the way the immune system reacts to allergens beyond the immunotherapy treatment course [5], biologic therapy withdrawal usually leads to asthma relapse [4]. Thus, a low adherence rate to inhaled treatment in patients undergoing biologic therapy raises some issues related to sustainability.




ico

Anticoagulants Safety and Effectiveness in General Practice: A Nationwide Prospective Cohort Study [Original Research]

PURPOSE

Most real-world studies on anticoagulants have been based on health insurance databases or performed in secondary care. The aim of this study was to compare safety and effectiveness between patients treated with vitamin K antagonists (VKAs) and patients treated with direct oral anticoagulants (DOACs) in a general practice setting.

METHODS

The CACAO study (Comparison of Accidents and their Circumstances with Oral Anticoagulants) is a multicenter prospective cohort study conducted among ambulatory patients taking an oral anticoagulant. Participants were patients from the study’s cross-sectional phase receiving oral anticoagulants because of nonvalvular atrial fibrillation, for secondary prevention of venous thromboembolism, or both. They were followed as usual for 1 year by their general practitioners, who collected data on changes in therapy, thromboembolic events, bleeding, and deaths. All events were adjudicated by an independent committee. We used a propensity score and a Cox regression model to derive hazard ratios.

RESULTS

Between April and December 2014, a total of 3,082 patients were included. At 1 year, 42 patients (1.7%) had experienced an arterial or venous event; 151 (6.1%) had experienced bleeding, including 47 (1.9%) who experienced major bleeding; and 105 (4.1%) had died. There was no significant difference between the VKA and DOAC groups regarding arterial or venous events, or major bleeding. The VKA group had a lower risk of overall bleeding (hazard ratio = 0.65; 95% CI, 0.43-0.98) but twice the risk of death (hazard ratio = 1.98; 95% CI, 1.15-3.42).

CONCLUSIONS

VKAs and DOACs had fairly similar safety and effectiveness in general practice. The substantially higher incidence of deaths with VKAs is consistent with known data from health insurance databases and calls for further research to understand its cause.




ico

Hydrogen Peroxide-Mediated Oxygen Enrichment Eradicates Helicobacter pylori In Vitro and In Vivo [Experimental Therapeutics]

Helicobacter pylori is an important risk factor for gastric ulcers. However, antibacterial therapies increase the resistance rate and decrease the eradication rate of H. pylori. Inspired by the microaerophilic characteristics of H. pylori, we aimed at effectively establishing an oxygen-enriched environment to eradicate and prevent the recurrence of H. pylori. The effect and the mechanism of an oxygen-enriched environment in eradicating H. pylori and preventing the recurrence were explored in vitro and in vivo. During oral administration and after drug withdrawal, H. pylori counts were evaluated by Giemsa staining in animal cohorts. An oxygen-enriched environment in which H. pylori could not survive was successfully established by adding hydrogen peroxide into several solutions and rabbit gastric juice. Hydrogen peroxide effectively killed H. pylori in Columbia blood agar and special peptone broth. Minimum inhibition concentrations and minimum bactericidal concentrations of hydrogen peroxide were both relatively stable after promotion of resistance for 30 generations, indicating that hydrogen peroxide did not easily promote resistance in H. pylori. In models of Mongolian gerbils and Kunming mice, hydrogen peroxide has been shown to significantly eradicate and effectively prevent the recurrence of H. pylori without toxicity and damage to the gastric mucosa. The mechanism of hydrogen peroxide causing H. pylori death was related to the disruption of bacterial cell membranes. The oxygen-enriched environment achieved by hydrogen peroxide eradicates and prevents the recurrence of H. pylori by damaging bacterial cell membranes. Hydrogen peroxide thus provides an attractive candidate for anti-H. pylori treatment.




ico

Increased B-cell ICOSL Expression Improves Chemotherapy Response [Immunology]

A chemotherapy-induced shift to ICOSL+ B cells in breast tumors correlated with better survival.




ico

Công ty Tài chính CP HANDICO




ico

Savico MegaMall Long Biên

Savico MegaMall Long Biên được xây dựng trên khu đất số 7-9 đường Nguyễn Văn Linh, phường Gia Thụy, quận Long Biên, Hà Nội – vị trí đắc địa phía Đông thành phố, giao thông thuận tiện, chỉ cách nút giao thông Cầu Chui gần 500m và khoảng cách tới trung tâm Hoàn Kiếm khoảng 5km.




ico

Công nghệ in 3D giúp dân nghèo Mexico có nhà ở

Cộng đồng nhà in 3D đầu tiên trên thế giới đang thành hình ở vùng quê xa xôi thuộc Mexico. Đây là giải pháp nhằm giảm thiểu tình trạng vô gia cư và cung cấp nơi ở an toàn, tiện nghi cho những người dân nghèo.




ico

Công ty CP Kiến trúc và Xây dựng AICOVINA




ico

Công ty CP Đầu tư Bất động sản Hapulico




ico

How a flawed mentality led to Silicon Valley’s meteoric rise

In the memoir Uncanny Valley, Anna Wiener examines the collective hyperconfidence that has enabled the tech sector’s meteoric growth